logo

ORCHID CEL(NSDQ:ORCH)
Orchid Cellmark provides identity DNA testing services for the human identity and agriculture markets. In the human identity area, the company provides DNA testing services for forensic, family relationship and security applications. In the agriculture field, Orchid Cellmark provides DNA testing services for food safety and selective trait breeding. Orchid Cellmark''s strong market positions in these segments reflect the company''s accredited laboratories in the U.S. and U.K. and its innovative genetic analysis technologies and expertise.
# Employees: 410
Address: 4390 US Route One,Princeton,NJ,USA
Phone: 609 750-2200
Fax: 609 750-6405
Website: www.orchid.com
Email: mail@orchid.com
Sector: Medical
Industry: MED-BIOMED/GENE
Executive Officers
George H. Poste Ph.D. (Chrmn.)
Thomas A. Bologna (C.E.O.)
James F. Smith (V.P.; C.F.O.)
James Beery (Dir.)
Nicole S. Williams (Dir.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 3/15/2010
Mean EPS (Next Qtr): ($0.01)
Mean EPS (Year): ($0.01)
Mean Estimate(Long Term): ($0.01)
P/E Ratio(Based on EPS estimate): -0.010
Number of Estimates: 0
Shares Performance
Period ORCH Compare to S&P
YTD 134.33 % 93.93 %
4 Weeks 2.61 % 1.51 %
12 Weeks -10.49 % -15.61 %
Shares Information
Analyst Coverage: N
Avg Volume: 16716
Shares Outstanding: 29M
Market Cap: $0.05B
52 Week High: $2.07
52 Week Low: $0.47
P/E Ratio: -0.010
PEG Ratio: -0.010
Split: On 3/31/2004 ORCH split by factor of 0.200
Earnings Performance
EPS Growth in Last Quarter: 0.00 %
EPS Growth in Last Year: 60.00 %
Sales Growth in Last Quarter: -0.09 %
Sales Growth in Last Quarter: -1.33 %
Financials
Qtr Book Value: $1.06
Cash Flow/Share: $24.97
Change in Payout Ratio: -0.010
Price/Sales: 0.840
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia